BusinessChemical and MaterialsScienceTechnologyTop Stories

Global Genotyping Market Report 2019 Estimating CAGR 24.22% Growth by 2024, A Report By Illumina, Thermo Fisher Scientific, Agilent Technologies, Bioline, Qiagen, Danaher, F. Hoffmann-La Roche and others

Production, consumption, revenue, gross margin, cost, gross, market share, CAGR, and genotyping market influencing factors are outlined in this report. This report includes all company profiles for top players and brands as well as a synopsis of market definition, classifications and trends in the market. The genotyping market’s drivers and limitations were derived from a well-known SWOT analysis method. Regional market segmentation included North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa’s historical and forecast mandates. We took up their company profiles in order to truly understand these key players and brands. The genotyping report provides a far-reaching analysis of the genotyping market by type, application, player, and region. The Global genotyping Market Report has published all business profiles of leading players and brands. This report focuses on genotyping global, regional and business volume and value.

Download Sample PDF Report

Major Market Drivers and Restraints Rising prevalence of genetic diseases, such as Alzheimer’s, Parkinson’s, hemophilia, thalassemia and turner syndrome, Early diagnosis and rapid sequencing helps professionals for the treatment, Technological developments in DNA sequencing, Deteriorating prices of DNA sequencing, Rising significance of SNP genotyping, Increasing demand for genome analysis in animal and plant livestock, Unfavorable reimbursement policies.

Key Players: Global Genotyping market:

  • Illumina
  • Thermo Fisher Scientific
  • Agilent Technologies
  • Bioline
  • Qiagen
  • Danaher
  • Hoffmann-La Roche
  • General Electric Company
  • Sequenom
  • BiogeniQ
  • Envigo
  • Helix
  • LGC Limited
  • Genotypic Technology
  • Eurofins Genomics
  • Biofortuna
  • Agena Bioscience
  • BioTechniques
  • Precision Biomarker Resources
  • TrimGen Corporation
  • 23andMe
  • Xcelris Genomic
  • Integrated DNA Technologies
  • BioTek Instruments

Avail Awesome Discount

Market Analysis The global genotyping market accounted to USD 7.58 billion in 2018 growing at a CAGR of 24.22% during the forecast period of 2019 to 2024. The upcoming market report contains data for historic years 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2024.

Strategic Points Covered in TOC:
Chapter 1: Introduction, market driving force product scope, market risk, market overview, and market opportunities of the global genotyping market
Chapter 2: Evaluating the leading manufacturers of the global genotyping market which consists of its revenue, sales, and price of the products
Chapter 3: Displaying the competitive nature among key manufacturers, with market share, revenue, and sales
Chapter 4: Presenting global genotyping market by regions, market share and with revenue and sales for the projected period
Chapter 5, 6, 7, 8 and 9: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries in these various regions.

Get Detailed TOC

Market Segmentation: Global Genotyping Market

  • The global genotyping market is segmented by product and services into instruments, reagents & kits, bioinformatics software and genotyping services, Instruments are further sub segmented into sequencers & amplifiers and analyzers.
  • On the basis of technology the market is segmented into microarray, capillary electrophoresis, sequencing, PCR and Maldi-tof. Capillary electrophoresis is further sub segmented into restriction fragment length polymorphism (RFLP), amplified fragment length polymorphisms (AFLP) and single strand conformation polymorphism (SSCP). Sequencing is further sub segmented into next generation sequencing (NGS), Sanger sequencing and pyrosequencing. Polymerase Chain Reaction (PCR) is further sub segmented into real time PCR and digital PCR.
  • On the basis of application the market is segmented into pharmacogenomics, diagnostic research, animal genetics and agricultural biotechnology.
  • By end user the market is segmented into pharmaceutical and biopharmaceutical companies, diagnostic & research laboratories and academic institutions.

Market Segment by Regions, regional analysis covers:

  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, UK, Russia and Italy)
  • Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • South America (Brazil, Argentina, Colombia)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Analysis The genotyping market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of genotyping market for global, Europe, North America, Asia Pacific and South America.

Speak to Author



Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *